DRG International Featured as Highlight of AACC 2011

Mountainside, NJ (August 2011) - DRG International was proud to be a participant at the American Association of Clinical Chemistry AACC 2011, the largest Clinical Lab Exposition in the World, held on July 26-28, 2011 at the Georgia World Congress Center in Atlanta, GA USA.  AACC conferences give diagnostic medicine industry leaders an opportunity to interact with their peers and learn about the newest technologies and procedures in their field.

DRG International has exhibited at the AACC since 1989 and over the past 22 years has highlighted its most exciting and cutting edge products.  This year was no exception as once again they were well received by the widely diverse international audience.  DRG’s presence was truly felt as they had representatives from several of their international subsidiaries including China, Germany, Russia and Poland on hand at this year’s show.  

“DRG International was honored to be an important part of AACC 2011 and we look forward to continued opportunities to provide valuable technology for the medical diagnostics and clinical chemistry field,” said Dr. Cyril E. Geacintov, CEO and President, DRG International.

DRG International was proud to showcase these products to diagnostics community gathered at AACC:

·         ELISAS: Active RENIN (Hypertension), Amyloid beta 1-40 (serum), anti-Amyloid-beta Ab (Alzheimer’s disease), Hepcidin-25 c- terminal, Pro-Hepcidin (Iron Metabolism) and PLGF (Preeclampsia)

·         Tumor Markers: TM-CA 15-3, TM-CA 125, TM-CA 19-9, TM-CA 72-4, TM-CYFRA 21-1, Afamin, CYR 61,

Crypto-1, L1-CAM, free PSA and NOV

·         Saliva ELISA: Cortisol, DHEA, Estradiol, 17a OH Progesterone and Testosterone

·         Infectious Diseases ELISA Kits: Chlamydia trachomatis (Ag, IgA, IgG, IgM), Fasciola IgG, and Treponema pallidum Screen

·         DRG: Hybrid.XL®(scheduled for 2012 RELEASE!):A fully automated random access analyzer for immunoassays and clinical chemistry.

“DRG International is a global innovator of high-quality medical diagnostics and equipment and provides the medical and research community with effective tools to build a healthier future,” said Mr. Michael Martini, the companies Director of Sales. “It gives me great pleasure to be a part of the DRG family.”

DRG’s presence at AACC 2011 demonstrated why the company continues to be a leader in diagnostic medicine.